The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
ID: ALA1075638
PubChem CID: 4615357
Max Phase: Preclinical
Molecular Formula: C13H9ClN4O
Molecular Weight: 272.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1cnn2cccnc12
Standard InChI: InChI=1S/C13H9ClN4O/c14-10-4-1-2-5-11(10)17-13(19)9-8-16-18-7-3-6-15-12(9)18/h1-8H,(H,17,19)
Standard InChI Key: NWAGLANFQJMTLN-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
1.2520 -14.2957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2509 -15.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9652 -15.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9634 -13.8832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6784 -14.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6832 -15.1180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4703 -15.3688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9519 -14.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4625 -14.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4795 -13.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2009 -12.8106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7731 -12.7846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7881 -11.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5140 -11.5644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5294 -10.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8246 -10.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0986 -10.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0868 -11.5406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3666 -11.9422 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 2 0
4 1 2 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 2 0
17 18 2 0
18 13 1 0
8 9 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.70 | Molecular Weight (Monoisotopic): 272.0465 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 59.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.37 | CX Basic pKa: 0.42 | CX LogP: 2.35 | CX LogD: 2.35 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -2.78 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |